Try our Advanced Search for more refined results
December 05, 2013
Teva Pharmaceuticals USA Inc. et al v. Forest Laboratories Inc.
Case Number:
1:13-cv-02002
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 25, 2016
Teva, Forest Settle Patent Fight Over $759M Namenda XR
A 2½-year patent battle over Forest Laboratories Inc.'s Alzheimer's drug Namenda XR ended in a settlement late Friday, just ahead of a planned five-day trial on federal infringement claims filed in Delaware federal court by Teva Pharmaceuticals USA Inc. and Mayne Pharma International Pty Ltd.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login